Upregulation of C-X-C chemokine receptor type 1 expression is associated with late-stage gastric adenocarcinoma

Experimental and Therapeutic Medicine

Volumn 4, Issue 1, 2012, Pages 55-60

  Wang, Jun Pu ^a   Hu, Wan Ming ^a   Wang, Kuan Song ^a   Luo, Bai Hua ^a   Wu, Chang ^a   Chen, Zhi Hong ^a   Luo, Geng Qiu ^a   Liu, Yu Wu ^a   Liu, Qin Lai ^a   Yu, Jun ^b   Li, Jing He ^a   Wen, Ji Fang ^a  

^a School of Basic Medicine   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

C X C chemokine receptor type 1; Chemokine; Gastric adenocarcinoma; Tumor cell

Indexed keywords

CD34 ANTIGEN; CHEMOKINE RECEPTOR CXCR1; MONOCLONAL ANTIBODY;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER TISSUE; CONTROLLED STUDY; FEMALE; GASTRECTOMY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULAR DENSITY; MICROVASCULATURE; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; STOMACH ADENOCARCINOMA;

EID: 84865760502     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2012.568     Document Type: Article

References (52)

1. Alberts SR, Cervantes A and van de Velde CJ: Gastric cancer: epidemiology, pathology and treatment. Ann Oncol 14 (Suppl 2): 31-36, 2003.
2. Yang L: Incidence and mortality of gastric cancer in China. World J Gastroenterol 12: 17-20, 2006.
3. Lu JB, Sun XB, Dai DX, et al: Epidemiology of gastroenterologic cancer in Henan Province, China. World J Gastroenterol 9: 2400-2403, 2003.
4. Hyung WJ, Noh SH, Yoo CH, et al: Prognostic significance of metastatic lymph node ratio in T3 gastric cancer. World J Surg 26: 323-329, 2002.
5. Park JY, Park KH, Bang S, et al: CXCL5 overexpression is associated with late stage gastric cancer. J Cancer Res Clin Oncol 133: 835-840, 2007
6. Fidler IJ: Critical determinants of metastasis. Semin Cancer Biol 12: 89-96, 2002.
7. Murphy PM, Baggiolini M, Charo IF, et al: International union of pharmacology. XXII. Nomenclature for chemokine receptors. Pharmacol Rev 52: 145-176, 2000.
8. Zlotnik A and Yoshie O: Chemokines: a new classification system and their role in immunity. Immunity 12: 121-127, 2000.
9. Rossi D and Zlotnik A: The biology of chemokines and their receptors. Annu Rev Immunol 18: 217-243, 2000.
10. Balkwill F and Mantovani A: Inflammation and cancer: back to Virchow? Lancet 357: 539-545, 2001.
11. Muller A, Homey B, Soto H, et al: Involvement of chemokine receptors in breast cancer metastasis. Nature 410: 50-56, 2001.
12. Johrer K, Zelle-Rieser C, Perathoner A, et al: Up-regulation of functional chemokine receptor CCR3 in human renal cell carcinoma. Clin Cancer Res 11: 2459-2465, 2005.
13. Scotton CJ, Wilson JL, Milliken D, Stamp G and Balkwill FR: Epithelial cancer cell migration: a role for chemokine receptors? Cancer Res 61: 4961-4965, 2001.
14. Schimanski CC, Schwald S, Simiantonaki N, et al: Effect of chemokine receptors CXCR4 and CCR7 on the metastatic behavior of human colorectal cancer. Clin Cancer Res 11: 1743-1750, 2005.
15. Balkwill F: The significance of cancer cell expression of the chemokine receptor CXCR4. Semin Cancer Biol 14: 171-179, 2004.
16. Lazennec G and Richmond A: Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 16: 133-144, 2010.
17. Charo IF and Ransohoff RM: The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354: 610-621, 2006.
18. Tan MC, Goedegebuure PS, Belt BA, et al: Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer. J Immunol 182: 1746-1755, 2009.
19. Tanaka T, Bai Z, Srinoulprasert Y, Yang BG, Hayasaka H and Miyasaka M: Chemokines in tumor progression and metastasis. Cancer Sci 96: 317-322, 2005.
20. Hu JY, Deng XY, Bian XW, et al: The expression of functional chemokine receptor CXCR4 is associated with the metastatic potential of human nasopharyngeal carcinoma. Clin Cancer Res 11: 4658-4665, 2005.
21. Waugh DJ and Wilson C: The interleukin-8 pathway in cancer. Clin Cancer Res 14: 6735-6741, 2008.
22. Ginestier C, Liu S, Diebel ME, et al: CXCR1 blockade selectively targets human breast cancer stem cells in vitro and in xenografts. J Clin Invest 120: 485-497, 2010.
23. Singh S, Nannuru KC, Sadanandam A, Varney ML and Singh RK: CXCR1 and CXCR2 enhances human melanoma tumourigenesis, growth and invasion. Br J Cancer 100: 1638-1646, 2009.
24. Eck M, Schmausser B, Scheller K, Brandlein S and Muller-Hermelink HK: Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma. Clin Exp Immunol 134: 508-515, 2003.
25. Kitadai Y, Takahashi Y, Haruma K, et al: Transfection of interleukin-8 increases angiogenesis and tumorigenesis of human gastric carcinoma cells in nude mice. Br J Cancer 81: 647-653, 1999.
26. Lin BR, Chang CC, Chen LR, et al: Cysteine-rich 61 (CCN1) enhances chemotactic migration, transendothelial cell migration, and intravasation by concomitantly up-regulating chemokine receptor 1 and 2. Mol Cancer Res 5: 1111-1123, 2007.
27. Croker AK, Goodale D, Chu J, et al: High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability. J Cell Mol Med 13: 2236-2252, 2009.
28. Kitadai Y, Haruma K, Mukaida N, et al: Regulation of disease-progression genes in human gastric carcinoma cells by interleukin 8. Clin Cancer Res 6: 2735-2740, 2000.
29. Ju DW, Wei PK, Lin HM, Sun DZ, Yu S and Xiu LJ: Effects of Xiaotan Sanjie decoction on expressions of interleukin-8 and its receptors in gastric tumor xenografts and gastric tissue adjacent to the tumor in mice. Zhong Xi Yi Jie He Xue Bao 8: 74-79, 2010 (In Chinese).
30. Wulfing P, Kersting C, Tio J, et al: Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer. Clin Cancer Res 10: 2393-2400, 2004.
31. Miyazaki H, Patel V, Wang H, Edmunds RK, Gutkind JS and Yeudall WA: Down-regulation of CXCL5 inhibits squamous carcinogenesis. Cancer Res 66: 4279-4284, 2006.
32. Richards BL, Eisma RJ, Spiro JD, Lindquist RL and Kreutzer DL: Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma. Am J Surg 174: 507-512, 1997.
33. Kakinuma T and Hwang ST: Chemokines, chemokine receptors, and cancer metastasis. J Leukoc Biol 79: 639-651, 2006.
34. Ruffini PA, Morandi P, Cabioglu N, Altundag K and Cristofanilli M: Manipulating the chemokine-chemokine receptor network to treat cancer. Cancer 109: 2392-2404, 2007.
35. Balakin KV, Ivanenkov YA, Tkachenko SE, Kiselyov AS and Ivachtchenko AV: Regulators of chemokine receptor activity as promising anticancer therapeutics. Curr Cancer Drug Targets 8: 299-340, 2008.
36. Koizumi K, Hojo S, Akashi T, Yasumoto K and Saiki I: Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response. Cancer Sci 98: 1652-1658, 2007.
37. Wang D, Sai J, Carter G, Sachpatzidis A, Lolis E and Richmond A: PAK1 kinase is required for CXCL1-induced chemotaxis. Biochemistry 41: 7100-7107, 2002.
38. Schraufstatter IU, Chung J and Burger M: IL-8 activates endothelial cell CXCR1 and CXCR2 through Rho and Rac signaling pathways. Am J Physiol Lung Cell Mol Physiol 280: L1094-L1103, 2001.
39. Venkatakrishnan G, Salgia R and Groopman JE: Chemokine receptors CXCR-1/2 activate mitogen-activated protein kinase via the epidermal growth factor receptor in ovarian cancer cells. J Biol Chem 275: 6868-6875, 2000.
40. Bonacchi A, Romagnani P, Romanelli RG, et al: Signal transduction by the chemokine receptor CXCR3: activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes. J Biol Chem 276: 9945-9954, 2001.
41. Chandrasekar B, Melby PC, Sarau HM, et al: Chemokine-cytokine cross-talk. The ELR+ CXC chemokine LIX (CXCL5) amplifies a proinflammatory cytokine response via a phosphatidylinositol 3-kinase-NF-kappa B pathway. J Biol Chem 278: 4675-4686, 2003.
42. Chandrasekar B, Bysani S and Mummidi S: CXCL16 signals via Gi, phosphatidylinositol 3-kinase, Akt, I kappa B kinase, and nuclear factor-kappa B and induces cell-cell adhesion and aortic smooth muscle cell proliferation. J Biol Chem 279: 3188-3196, 2004.
43. Caruso RA, Bellocco R, Pagano M, Bertoli G, Rigoli L and Inferrera C: Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy. Mod Pathol 15: 831-837, 2002.
44. Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A and Musiani P: The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 97: 339-345, 2001.
45. Welch DR, Schissel DJ, Howrey RP and Aeed PA: Tumor-elicited polymorphonuclear cells, in contrast to 'normal' circulating polymorphonuclear cells, stimulate invasive and metastatic potentials of rat mammary adenocarcinoma cells. Proc Natl Acad Sci USA 86: 5859-5863, 1989.
46. De Larco JE, Wuertz BR and Furcht LT: The potential role of neutrophils in promoting the metastatic phenotype of tumors releasing interleukin-8. Clin Cancer Res 10: 4895-4900, 2004.
47. Schmausser B, Josenhans C, Endrich S, et al: Downregulation of CXCR1 and CXCR2 expression on human neutrophils by Helicobacter pylori: a new pathomechanism in H. pylori infection? Infect Immun 72: 6773-6779, 2004.
48. Backhed F, Torstensson E, Seguin D, Richter-Dahlfors A and Rokbi B: Helicobacter pylori infection induces interleukin-8 receptor expression in the human gastric epithelium. Infect Immun 71: 3357-3360, 2003.
49. Gabellini C, Trisciuoglio D, Desideri M, et al: Functional activity of CXCL8 receptors, CXCR1 and CXCR2, on human malignant melanoma progression. Eur J Cancer 45: 2618-2627, 2009.
50. Charafe-Jauffret E, Ginestier C, Iovino F, et al: Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Res 69: 1302-1313, 2009.
51. Folkman J: Angiogenesis and apoptosis. Semin Cancer Biol 13: 159-167, 2003.
52. White ES, Flaherty KR, Carskadon S, et al: Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. Clin Cancer Res 9: 853-860, 2003.